A detailed history of Pnc Financial Services Group, Inc. transactions in Personalis, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 12 shares of PSNL stock, worth $93. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$93
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$4.38 - $7.51 $52 - $90
12 New
12 $0
Q2 2022

Aug 12, 2022

BUY
$3.27 - $8.76 $1,013 - $2,715
310 New
310 $1,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $359M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.